Organotypic culture model of mouse meibomian gland as a screening platform for risk factors related to meibomian gland dysfunction

被引:2
|
作者
Wang, Guoliang [1 ,2 ,3 ]
Xu, Lina [3 ,4 ]
Shi, Ruize [4 ]
Ye, Yingyue [1 ,2 ]
Zeng, Baihui [4 ]
Yang, Xiuqin [1 ,2 ]
Liu, Zeyu [1 ,2 ,5 ]
Liu, Zhen [1 ,2 ,5 ]
Wang, Shurong [3 ,9 ]
Xue, Yuhua [1 ,2 ,8 ]
Li, Cheng [1 ,2 ,5 ,6 ,7 ]
机构
[1] Xiamen Univ, Eye Inst, Sch Pharmaceut Sci, Xiamen 361102, Fujian, Peoples R China
[2] Xiamen Univ, Affiliated Xiamen Eye Ctr, Xiamen 361102, Fujian, Peoples R China
[3] Jilin Univ, China Japan Union Hosp, Dept Ophthalmol, Changchun 130033, Jilin, Peoples R China
[4] Second Hosp Jilin Univ, Dept Ophthalmol, Changchun 130041, Jilin, Peoples R China
[5] Fujian Prov Key Lab Ophthalmol & Visual Sci, Xiamen 361102, Fujian, Peoples R China
[6] Univ South China, Affiliated Hosp 1, Dept Ophthalmol, Hengyang 421001, Hunan, Peoples R China
[7] Xiamen Univ, Eye Inst, Xiangan Campus, 4th Floor, Chengyi Bldg,South Xiangan Rd, Xiamen 361102, Fujian, Peoples R China
[8] Xiamen Univ, Sch Pharmaceut Sci, Xiangan Campus, 4th Floor, Zhuangjin Bldg,South Xiangan Rd, Xiamen 361102, Fujian, Peoples R China
[9] Jilin Univ, China Japan Union Hosp, Dept Ophthalmol, 126 Xiantai St, Changchun 130033, Jilin, Peoples R China
来源
OCULAR SURFACE | 2023年 / 30卷
基金
中国国家自然科学基金; 国家重点研发计划;
关键词
Organotypic culture; Meibomian gland; Air-liquid interface; Lipid synthesis; Dexamethasone; EPITHELIAL-CELLS; MEIBOCYTE DIFFERENTIATION;
D O I
10.1016/j.jtos.2023.08.007
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: Meibomian glands (MGs) are crucial for maintaining tear film stability and ocular surface health. Here, we aim to establish a novel organotypic culture model of MGs and explore the risk factors of MG dysfunction (MGD).Methods: We developed a novel organotypic culture model for MGs at the air-liquid interface. The viability and cell proliferation of MGs were assessed using CCK-8, immunofluorescence, and qPCR. Lipid accumulation was evaluated by Nile red staining and microscopic examination. Protein expression levels were evaluated by immunofluorescence and Western blot assay. EdU assay was employed to track the proliferation of acinar cells. The validity of the model was confirmed through culturing MGs from mice of different ages and incorporating certain drugs (Dex) into the culture system.Results: Utilizing the novel culture model, the MG tissue exhibited sustained viability, cellular division, and continuous production of lipids for a duration of 7 days. Lipid droplets formed were directly visualized using light field microscopy. Through the cultivation of aged mice's MGs, it was discovered that aging resulted in diminished proliferation and lipid synthesis, along with an aberrant increase in Krt10 expression. Further application of this model showed that Dex treatment diminished MG's proliferation and lipid synthesis. Finally, an in vivo study was conducted to provide additional confirmation of the phenomenon of Dex-induced abnormalities.Conclusions: In this study, a stable organotypic culture model of the MGs was established. The organotypic culture model offers a valuable tool to investigate the pathophysiological mechanisms and facilitate drug screening for MG-related diseases.
引用
收藏
页码:73 / 84
页数:12
相关论文
共 50 条
  • [41] Anterior Lamellar Repositioning in the Management of Meibomian Gland Inversion Secondary to Meibomian Gland Dysfunction
    Samia-Aly, Emma
    Barua, Ankur R.
    Patel, Radhika P.
    Mehta, Purnima
    [J]. OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2021, 37 (06): : 560 - 563
  • [42] Impact of the 2011 International Workshop on Meibomian Gland Dysfunction on clinical trial attributes for meibomian gland dysfunction
    Ngo, William
    Gann, Drew
    Nichols, Jason J.
    [J]. OCULAR SURFACE, 2020, 18 (01): : 27 - 30
  • [43] Risk associated with treatments for meibomian gland dysfunction Reply
    Magno, M. S.
    Olafsson, J.
    Beining, M.
    Moschowits, E.
    Lagali, N.
    Wolffsohn, J. S.
    Craig, J. P.
    Vehof, J.
    Dartt, D. A.
    Utheim, T. P.
    [J]. CONTACT LENS & ANTERIOR EYE, 2023, 46 (02):
  • [44] Generation of a novel rabbit model for meibomian gland dysfunction
    Donthineni, Pragnya Rao
    Prasad, Deeksha
    Salman, Mohammed
    Jakati, Saumya
    bokara, Kiran
    Basu, Sayan
    Singh, Vivek
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [45] Meibomian Gland Dysfunction and Dyslipidemia: A Review
    Braich, Puneet Singh
    Mann, Amarjot S.
    Brar, Vikram
    Leffler, Christopher T.
    Lal, Vikram
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [46] Meibomian gland dysfunction: hyperkeratinization or atrophy?
    James V. Jester
    Geraint J. Parfitt
    Donald J. Brown
    [J]. BMC Ophthalmology, 15
  • [47] Interventional therapies in meibomian gland dysfunction
    Handzel, Daniel M.
    Sekundo, Walter
    Meyer, Carsten H.
    [J]. SPEKTRUM DER AUGENHEILKUNDE, 2013, 27 (04) : 196 - 199
  • [48] Hyperlipidemia induces meibomian gland dysfunction
    Bu, Jinghua
    Wu, Yang
    Cai, Xiaoxin
    Jiang, Nan
    Jeyalatha, M. Vimalin
    Yu, Jingwen
    He, Xin
    He, Hui
    Guo, Yuli
    Zhang, Mingjie
    Quantock, Andrew J.
    Liu, Zuguo
    Li, Wei
    [J]. OCULAR SURFACE, 2019, 17 (04): : 777 - 786
  • [49] Nonobvious Obstructive Meibomian Gland Dysfunction
    Blackie, Caroline A.
    Korb, Donald R.
    Knop, Eric
    Bedi, Raman
    Knop, Nadja
    Holland, Edward J.
    [J]. CORNEA, 2010, 29 (12) : 1333 - 1345
  • [50] MEIBOMIAN GLAND DYSFUNCTION IN CHRONIC BLEPHARITIS
    MATHERS, WD
    SHIELDS, WJ
    SACHDEV, MS
    PETROLL, WM
    JESTER, JV
    [J]. CORNEA, 1991, 10 (04) : 277 - 285